Powder: -20°C for 3 years | In solvent: -80°C for 1 year
FNC-TP, the intracellular active form of FNC, is a potent nucleoside reverse transcriptase inhibitor (NRTI) with broad-spectrum antiviral activity against HIV, HBV, and HCV.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | $ 1,255.00 |
Description | FNC-TP, the intracellular active form of FNC, is a potent nucleoside reverse transcriptase inhibitor (NRTI) with broad-spectrum antiviral activity against HIV, HBV, and HCV. |
In vitro | FNC (0.1-10 nM; 24-240 h) predominantly accumulates in HIV-1 target cells, exhibiting a retention rate of FNC-TP that is 2-4 times greater compared to other cell types[1]. |
In vivo | FNC (1-6 mg/kg; administered orally once) is capable of penetrating rhesus macaque PBMCs, where it is converted into its active form, the nucleoside triphosphate FNC-TP[1]. |
Molecular Weight | 526.16 |
Formula | C9H14FN6O13P3 |
CAS No. | 2457357-99-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
FNC-TP 2457357-99-0 FNC TP FNCTP inhibitor inhibit